Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants-Reference-Cited by-同舟云学术

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants

Published:2022-04 Issue:9 Volume:185 Page:1539-1548.e5
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Servellita Venice,Syed Abdullah M.,Morris Mary Kate,Brazer Noah,Saldhi Prachi,Garcia-Knight Miguel,Sreekumar Bharath,Khalid Mir M.,Ciling Alison,Chen Pei-Yi,Kumar G. Renuka,Gliwa Amelia S.,Nguyen Jenny,Sotomayor-Gonzalez Alicia,Zhang Yueyuan,Frias Edwin,Prostko John,Hackett John,Andino Raul,Wadford Debra A.,Hanson Carl,Doudna Jennifer,Ott Melanie,Chiu Charles Y.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference31 articles.

1. Bushnell, B. (2022). BBMap, version 38.87. https://sourceforge.net/projects/bbmap/.

2. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies;Cao;Nature,2022

3. Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2;Case;Cell Host Microbe,2020

4. SARS-CoV-2 B.1.1.529 (Omicron) Variant—United States, December 1–8, 2021;MMWR Morb. Mortal. Wkly. Rep.,2021

5. Variants,2022

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence;Infectious Disorders - Drug Targets;2024-11

2. Impact of Anti-SARS-CoV-2 Vaccination on Disease Severity and Clinical Outcomes of Individuals Hospitalized for COVID-19 Throughout Successive Pandemic Waves: Data from an Italian Reference Hospital;Vaccines;2024-09-06

3. Biomimetic/Bioderived Nanoengineered Interfaces for Biosensor Applications: A Review;ACS Applied Nano Materials;2024-08-23

4. Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses;PLOS Pathogens;2024-08-15

5. Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1;Cell Reports;2024-08